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Early dynamic fate changes in haemogenic
endothelium characterized at the single-cell level
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Haematopoietic stem cells (HSCs) are the founding cells of the adult haematopoietic system,
born during ontogeny from a specialized subset of endothelium, the haemogenic endothelium
(HE) via an endothelial-to-haematopoietic transition (EHT). Although recently imaged in real
time, the underlying mechanism of EHT is still poorly understood. We have generated a Runx1
þ 23 enhancer-reporter transgenic mouse (23GFP) for the prospective isolation of HE
throughout embryonic development. Here we perform functional analysis of over 1,800 and
transcriptional analysis of 268 single 23GFPþ HE cells to explore the onset of EHT at the
single-cell level. We show that initiation of the haematopoietic programme occurs in cells still
embedded in the endothelial layer, and is accompanied by a previously unrecognized early
loss of endothelial potential before HSCs emerge. Our data therefore provide important
insights on the timeline of early haematopoietic commitment.
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D
eﬁnitive haematopoietic progenitors and long-term hae-
matopoietic stem cells (HSCs) are thought to originate
during ontogeny from a specialized subset of endothe-
lium, so-called haemogenic endothelium (HE)1–4. Arguably the
strongest support for the endothelial origin of haematopoietic
cells comes from recent time-lapse imaging studies that directly
visualized the transition of endothelium into blood, both in vitro5
and in/ex vivo6–9. What has remained unclear, however, is at
what stage during this endothelial-to-haematopoietic transition
(EHT) cells actually change their fate and initiate the process of
commitment to the haematopoietic lineage, and how this fate
change is regulated at the molecular level. Addressing these and
other questions will be critical to obtain a better understanding of
the cellular hierarchies and the signalling and transcription factor
gene regulatory networks that underlie the speciﬁcation of
deﬁnitive hematopoietic stem and progenitor cells. This in turn
will inform the rational development of future regenerative
therapies involving the efﬁcient generation of deﬁnitive HSCs
from embryonic stem cells, induced pluripotent cells or via direct
reprogramming, which at present has not been possible10–16.
A major hurdle in dissecting the process of EHT has been the
lack of positive ﬂuorescent markers speciﬁc for haemogenic, but
not non-haemogenic, endothelium. To obtain such a marker, we
have initiated studies into the regulation of the transcription
factor Runx1, which is expressed during, and critically required
for EHT7–9,11,17–20. We recently identiﬁed the Runx1 þ 23
haematopoietic enhancer and generated transgenic mouse lines
carrying a LacZ or Gfp reporter gene transcribed from the hsp68
minimal promoter under the spatiotemporal control of the Runx1
þ 23 enhancer21,22. In these lines, reporter gene expression
recapitulates endogenous Runx1 expression in haematopoietic
sites only, where þ 23-mediated reporter gene expression is
comparable with expression from a Runx1-LacZ knock-in
allele22. Indeed, functional assays showed that þ 23 enhancer-
reporter expression marked most, if not all, of the emerging
haematopoietic stem and progenitor cells, similar to endogenous
Runx121,22. Importantly, we never observed reproducible
þ 23-mediated reporter gene expression in the non-
haematopoietic embryonic sites of endogenous Runx1 expression,
indicating the haematopoietic speciﬁcity of the þ 23 enhancer22.
In the present study, we establish that þ 23 enhancer-mediated
GFP expression (referred to as 23GFP throughout) prospectively
labels all haematopoietic-fated endothelial cells. Comprehensive
functional analysis of 1,800 single 23GFPþ haemogenic
endothelial cells and transcriptional analysis of 268 single
23GFPþ haemogenic endothelial cells reveals that HE is itself
highly transitory, initiating dynamic changes towards a haema-
topoietic fate earlier than previously recognized, two days before
HSCs emerge, while cells are still part of the endothelial wall.
Furthermore, initiation of the haematopoietic differentiation
programme is accompanied by a previously unrecognized early
loss of endothelial potential.
Results
The 23GFP transgene marks a subset of embryonic endothe-
lium. To obtain a positive ﬂuorescent marker for haemogenic
endothelium, we generated a transgenic reporter mouse line in
which the þ 23 enhancer of the haematopoietic master regulator
Runx1 mediates the expression of GFP speciﬁcally to the hae-
mogenic/haematopoietic sites of the developing embryo, in a
spatiotemporal pattern similar to the haematopoietic expression
of a Runx1-LacZ knock-in allele21,22; (Supplementary Fig. S1a–d).
In these 23GFP transgenic embryos, GFP was shown to mark
functionally deﬁned haematopoietic stem and progenitor cells21.
Non-haematopoietic sites of Runx1 expression are not marked by
the þ 23 enhancer22, indicative of its haematopoietic speciﬁcity.
Here, we further characterized the expression of the reporter-
enhancer transgene in haemogenic sites by immunostaining for
VE-Cadherin (VE-Cadh) expression. In addition to its reported
expression in haematopoietic cells21,22, 23GFP expression was
detected in a subset of VE-Cadhþ endothelial cells (ECs) of the
(paired) dorsal aorta(e) in the para-aortic splanchnopleura (PAS)/
aorta-gonad-mesonephros (AGM) region, the vitelline and
umbilical (VU) arteries, and the yolk sac vasculature (Fig. 1a;
Supplementary Fig. S1e,f). 23GFP expression was also observed in
placental vessels (Supplementary Fig. S1g)22. In this study, we
mainly focused on the haemogenic sites known to autonomously
generate HSCs: the PAS/AGM and VU arteries23–25 that contain
a deﬁnitive type HE26,27. In the PAS, 23GFP expression was
already prevalent in the endothelium of the paired dorsal aortae
at embryonic day (E) 8–8.5, when Runx1-LacZ expression
commences22, and before endogenous Runx1 protein expression
could be detected by immunoﬂuorescence (starting laterally in the
dorsal aorta from B23 somite pairs (sp)/E9.25; Fig. 1b). The
absence of other Runx1 regulatory elements and/or the lack of
Runx1-speciﬁc posttranscriptional regulation could underlie the
differences in onset of expression of the 23GFP reporter and
endogenous Runx1. To examine whether the early onset of
23GFP in ECs reﬂects a biologically distinct subset, we performed
genome-wide expression proﬁling of E8.5 23GFPþ and 23GFP
ECs, along with the ﬁrst emerging CD41þ haematopoietic
progenitor cells (HPCs; Fig. 1c). 23GFPþ and 23GFP ECs were
stringently gated as VE-CadhþTer119CD45CD41 , and
CD41þ HPC as 23GFPþVE-CadhþTer119CD45CD41þ
cells (Supplementary Fig. S1h). Hierarchical clustering of the
expression data revealed that E8.5 23GFPþ ECs have a distinct
transcriptional signature closer to the ﬁrst emerging CD41þ
HPCs than to the 23GFP endothelium (Fig. 1d). Five hundred
and sixteen annotated genes were differentially expressed between
the 23GFPþ and 23GFP ECs, including 45 transcription
factors and 11 endothelial junction genes (Supplementary
Data 1). The top differentially affected gene ontology processes
overrepresented in 23GFPþ ECs (green bars, Fig.1e) included
genes associated with angiogenesis and cell migration, indicative
of an active endothelial nature, and interestingly also genes
expressed in response to estradiol, which was recently implicated
in the formation of the hematopoietic system28. In conclusion,
23GFP expression is detected in a speciﬁc subset of the
endothelium that precedes and later overlaps with endogenous
Runx1 protein expression, suggesting that the 23GFP transgene
prospectively identiﬁes the HE.
23GFPþ endothelial cells are haemogenic. HE has been deﬁned
as cells with an endothelial morphology and phenotype
(cf. Fig. 1a,c) that form endothelial tubules in culture and are
competent to generate haematopoietic progeny29,30. To examine
the haemogenic potential of the 23GFPþ endothelium, 23GFPþ
and 23GFP VE-CadhþTer119CD45CD41 endothelial
cells (EC) were isolated from the E8.5 conceptus as before and
from the E10.5 AGMþVU (Supplementary Fig. S2b,c) and
cultured in bulk on OP9 stroma31 in conditions supporting the
generation of haematopoietic progeny. Consistently, only the
23GFPþ endothelium, and never the 23GFP endothelium, gave
rise to haematopoietic progeny, generating both myeloid and
lymphoid cells, (Fig. 2a–d; Supplementary Fig. S2d). Haemogenic
potential of the 23GFPþ endothelium was more robust at E10.5
than at E8.5 (Fig. 2b), an observation further supported by limiting
dilution experiments of 23GFPþ endothelium at E9.5 and E10.5
(Supplementary Fig. S2e). Similar results were obtained from
23GFPþ and 23GFP yolk sac endothelium (Supplementary
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Figure 1 | The Runx1 þ23 haematopoietic-speciﬁc enhancer marks a distinct subset of endothelium in mouse haemogenic sites. (a) VE-Cadh
immunostaining (red) and 23GFP transgene expression (green) in 10 mm cryosections through the posterior region of E8.5 (7–10 sp) and E10.5 (31–34 sp)
23GFP transgenic embryos. Nuclear stain (TO-PRO-3) in blue. Higher magniﬁcation images of the boxed areas show co-expression of VE-Cadh and 23GFP.
Arrowhead: example of 23GFP expression in VE-Cadhþ endothelial cells. Scale bar, 20mm. (b) Merged and single channel images of Runx1
immunohistochemistry on 23GFP expressing sections of E8.5 (10 sp) and E9.25 (23 sp). Arrowhead: 23GFP and Runx1 co-expression, asterisk: Runx1 but
no 23GFP expression. Ao, dorsal aorta; Hg, hind gut; Vit, vitelline artery; scale bar, 20mm. (c) Flow cytometric analysis further corroborates 23GFP
expression in E8.5 (4–12 sp) VE-CadhþTer119CD45CD41 endothelial cells. Representative dot plots and mean percentages±s.d. are from three
independent analyses of pooled tissues. Sort gates are indicated. (d) Hierarchical clustering and heatmap of whole-genome gene expression data
(Affymetrix) from 23GFPþ and 23GFP VE-CadhþTer119CD45CD41 EC and 23GFPþVE-CadhþTer119CD45CD41þ HPC. Numbers in
parentheses indicate the biological sample. There are 516 unique annotated probe IDs differentially expressed between 23GFPþ and 23GFP ECs
(see Supplementary Data 1 for the full list). The top differentially affected GO processes overrepresented in this list are shown in (e).
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Fig. S2f). Importantly, no signiﬁcant haematopoietic clonogenic
potential, indicative of the presence of HPCs rather than HE, was
detected in the 23GFPþ endothelial population (Supplementary
Fig. S2g). In summary, these results show that throughout
development, haemogenic potential segregates with the 23GFPþ
endothelium, allowing for the prospective isolation of cells fated to
undergo EHT.
23GFPþ HE loses its endothelial potential during develop-
ment. As well as the expression of endothelial markers, the ability
of cells to form endothelial tubules/sheets in OP9 culture is
considered a hallmark of endothelial potential and func-
tion10,11,29,32,33. Analysis of endothelial tubule/network
formation in OP9 cocultures supplemented with vascular
endothelial growth factor showed that the E8.5 23GFPþ and
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Figure 2 | Haemogenic endothelium is restricted to the 23GFPþ EC population. (a) Experimental approach for data shown in Figs 2–5. (b) Generation of
haematopoietic progeny by 23GFPþ or 23GFP VE-CadhþTer119CD45CD41 ECs from E8.5 (5–12 sp) concepti or E10.5 (29–35 sp) AGMþVU on
OP9 stroma. Black arrowhead: round semi-adherent haematopoietic cells; white arrowhead: adherent cobblestone-like cells (scale bar, 50 mm). Flow
cytometric analysis conﬁrmed the presence of CD45þ haematopoietic cells. Data are representative of at least three independent cocultures.
(c) Representative ﬂow cytometric analysis of haemogenic cultures demonstrates both B-lymphoid (CD19) and myeloid (Mac1 or Gr1) cell generation.
(d) May-Gru¨nwald Giemsa stained cytospins of haemogenic cultures reveal myeloid (arrowhead, and ii–iv) and blast-like (arrow and v) haematopoietic
cells. Asterisks point out OP9 stromal cells. Scale bar, 10 mm. (e) 23GFPþ or 23GFP VE-CadhþTer119CD45CD41 cells were isolated from E8.5
(5–12 sp) conceptus or E10.5 (29–35 sp) AGMþVU, and cultured on OP9 stroma to support endothelial tubule formation. Tubules were visualized by
CD31 staining after 4 days of culture. Representative images and quantiﬁcation (mean±s.d.) of endothelial tubules generated in OP9 cocultures by
23GFPþ or 23GFP VE-CadhþTer119CD45CD41 cells isolated from E8.5 (5–12 sp) conceptus or E10.5 (29–35 sp) AGMþVU (n¼ 3). Only very
limited endothelial tubule formation was observed in the 23GFPþ EC population at E10.5, shown is one of 11 tubules. Scale bar, 200mm.
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23GFP EC populations readily formed CD31þ vascular tubules
and networks at an equal frequency (Fig. 2e). At E10.5, this
capacity was severely reduced among the 23GFPþ ECs, but
maintained in the 23GFP ECs. Although a few endothelial
tubules/networks were detected in cultures of 23GFPþ cells,
these results challenged the concept of HE as a bona ﬁde
endothelial cell able to generate endothelial tubules or sheets
while also giving rise to haematopoietic progeny29. To explore
this directly, we performed clonal cultures of E8.5 to E10.5 HE. In
these cultures, a single 23GFPþ HE cell never had both
haematopoietic and endothelial potential (over 1,800 single cells
analysed; Table 1; Supplementary Fig. S2a). Haematopoietic
progeny and endothelial tubules were generated at frequencies
comparable with those obtained in bulk and limiting dilution
cultures, but never from the same cell (cf. Fig. 2e and
Supplementary Fig. S2e). Importantly, in line with previous
reports5,10,29,34, single E7.5 23GFPþ mesodermal (Flk1þVE-
Cadh /loCD41 ) cells plated in control experiments did give rise
to both haematopoietic and endothelial cells, which indicates that
our OP9 cultures can readout coexistence of haemogenic and
endothelial potential in single cells (Supplementary Fig. S3). In
conclusion, the failure to detect haemogenic and endothelial
potential in a single 23GFPþ HE cell indicates that if this
potential exists in these cells, it is exceedingly rare, lending no
experimental support for the conventional model depicted in
Fig. 3. Instead, we observed that 23GFPþ HE undergoes dynamic
functional changes over time, showing an increased capacity to
generate haematopoietic progeny, concomitant with an
unexpected early decrease in endothelial potential (Table 1;
Fig. 3). Importantly, this loss of endothelial potential was missed
in previous studies, presumably at least in part because without a
tool such as the 23GFP mice, HE could not be separated from
non-haemogenic ECs.
23GFPþ HE expresses key haematopoietic and endothelial
genes. To begin to analyse the molecular mechanisms that
underlie the functional changes of 23GFPþ HE, we performed
quantitative RT–PCR (qRT–PCR) on cells isolated from the E8.5
to E10.5 PAS/AGMþVU. As only few cells can be obtained from
these tissues, we used the Fluidigm platform, which allows for the
simultaneous analysis of multiple genes in small cell numbers.
Genes coding for transcription factors afﬁliated with the hae-
matopoietic lineage35,36 were analysed on samples of 25 cells
each, obtained from pooled tissues (Fig. 4). Non-haemogenic
ECs and emerging CD41þ HPCs isolated from the same embryos
were analysed in parallel. Strikingly, genes coding for
transcription factors associated with the early speciﬁcation of
the haematopoietic system such as Meis1, Gata2, Gata3 and Tal1
(Scl), were expressed at higher levels in 23GFPþ HE than in non-
haemogenic ECs. For Meis1, Gata2, and Gata3 this was apparent
already at E8.5. From E9.25, the haematopoietic master regulator
Runx1 was readily detected in the 23GFPþ HE but not in the
23GFP ECs. Expression of known Runx1 target genes such as
Gﬁ1 (ref. 37) and Sfpi1 (Pu.1)38 closely followed Runx1
expression in the HE. Other haematopoietic-afﬁliated genes (for
example, Myb, a marker of hematopoietic commitment39) also
followed this pattern. Altogether, these results support a stepwise
establishment of the haematopoietic programme in the 23GFPþ
HE starting already at E8.5.
Single-cell analysis reveals the transitory nature of HE. To
explore the dynamics of the haematopoietic commitment process
at the single-cell level at which fate changes actually occur, we
isolated 268 single 23GFPþ HE from E8.5 to E11.5 PAS/
AGMþVU (Table 2) and performed single-cell Fluidigm
qRT–PCR for 18 haematopoietic and endothelial-afﬁliated genes,
including 10 core haematopoietic transcription factors35,40. Two
hundred and eighty-ﬁve non-haemogenic ECs, 212 recently
emerged CD41þ HPCs, and 38 more mature haematopoietic
cells, referred to as CD45þ HPCs (23GFPþVE-
CadhþTer119CD41þCD45þ ) were analysed in parallel.
Principal component analysis (PCA) revealed the relationships
Table 1 | 23GFPþ HE undergoes dynamic functional changes early in development.
No. of wells with haematopoietic and/or endothelial progeny/no. wells seeded with a single cell (frequency)
Cell type Stage Haematopoietic and endothelial progeny Haematopoietic progeny Endothelial progeny
23GFPþ HE E8.5 0/805 0/805 55/805 (1:15)
E9.5 0/540 1/540 (1:540) 8/540 (1:68)
E10.5 0/539 11/539 (1:49) 5/539 (1:108)
23GFP EC E8.5 0/288 0/288 27/288 (1:11)
E9.5 0/234 0/234 13/234 (1:18)
E10.5 0/192 0/192 7/192 (1:27)
EC, endothelial cells, GFP, green ﬂuorescent protein; HE, haemogenic endothelium; sp, somite pair.
Haemogenic and endothelial tubule forming potential of individual 23GFPþ HE cells, as determined by clonal OP9 cocultures. Data are the total of 2–5 independent experiments performed on pooled
tissues of E8.5 PASþYS (4–10 sp), E9.25–9.5 PASþVU (17–27 sp), E10.5 AGMþVU (32–37 sp), apart from E10.5 23GFP cultures (1 experiment). Similar to the bulk cultures, 23GFP EC were unable
to generate haematopoietic progeny.
HE
Endothelial tubules
HPC
Conventional model
E10.5/11.5
HPCHE
Early onset model 
E8.5 E9.5-E10.5
Figure 3 | Early onset model of EHT. In the conventional model of EHT
(right side), haemogenic endothelium is considered as an endothelial cell
capable of generating endothelial tubules and giving rise to haematopoietic
progeny. This model is not supported by the functional data. In contrast, the
data suggest an alternative model of EHT, with 23GFPþ haemogenic
endothelium undergoing an early onset of haematopoietic differentiation,
and loss of endothelial potential.
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between all 803 individual cells (Fig. 5a). Non-haemogenic ECs
(blue) and the CD45þ HPCs (yellow) formed two clearly distinct
clusters along component 1. The endothelial genes Kdr, Tek and
the haematopoietic genes Sfpi1, Myb, Runx1, Gﬁ1 and Itgb3
contributed most to the separation of these cell types. In contrast,
CD41þ HPCs (red) were more scattered along component 1,
indicating a continuum in maturation towards fully determined
CD45þ HPCs (see also the E9.5 and E10.5 PCA plots in
Supplementary Fig. S4a). The 23GFPþ HE cells (green) were
scattered along component 1 and 2, showing increasing
segregation from the non-haemogenic ECs and intermingling
with CD41þ HPCs (Fig. 5a; Supplementary Fig S4a), thus
bearing out at the single-cell molecular level the dynamic
functional changes observed in this transitory population over
developmental time.
Analysis of gene expression on a per cell basis showed further
similarities and differences between 23GFPþ HE and 23GFP
ECs. At E8.5, both the 23GFPþ HE and 23GFP EC showed
stochastic, low-level sampling41 of genes associated with
haematopoietic differentiation (Runx1, Gﬁ1, Sfpi1 and c-Myb).
Moreover, both HE and non-haemogenic ECs widely expressed
Itga2b (CD41) mRNA, a marker previously reported to be speciﬁc
to HPCs42. After E8.5, Itga2b expression was undetectable in HE
and non-haemogenic ECs, to be expressed again when cells
develop into CD41þ /CD45þ HPCs. This unexpected43,44 early
endothelial expression of Itga2b was conﬁrmed by CD41
immunoﬂuorescence (Supplementary Fig. S5a,b), indicating that
nascent endothelium of the PAS expresses low levels of CD41. We
speculate that all nascent endothelium is competent to respond to
haematopoiesis-inducing signals45. Evidence of haematopoietic
development was however only seen among the 23GFPþ HE
cells, with B50% of the E8.5 HE showing upregulation of the
homeobox gene Meis1, in line with the population data (cf. Figs 4
and 5b). Interestingly, this increased Meis1 (ref. 46) expression in
HE was accompanied by a downregulation of Etv2, an Ets
transcription factor expressed in early endothelial cells47 (E8.5,
Fig. 5b, and see Supplementary Fig. S4b for the Pearson’s
correlation analysis), suggestive of a previously unrecognized
antagonistic relationship between Meis1 and Etv2 in establishing
the haematopoietic programme. Meis1 (as well as Gata2)
expression was maintained/increased in nearly all HE cells over
developmental time, contributing to their segregation from the
23GFP ECs (Fig. 5b). Thus, it appears that only the 23GFPþ
cells received and/or responded to haematopoiesis-inducing
signals and have begun their journey along the haematopoietic
lineage.
Haematopoietic speciﬁcation of HE initiates at E9.5. In the E9.5
PASþVU, B50% of the 23GFPþ HE expressed the master
haematopoietic regulator Runx1 (Fig. 5b). Only cells with the
highest Runx1 levels co-expressed known Runx1 target genes
such as Sfpi1 and Gﬁ1, indicating the further unfolding of the
haematopoietic programme. Correspondingly, these cells showed
decreased Kdr (Flk1) expression, establishing at the single-cell
level the reported antagonistic effect of Runx1 on Kdr48 (Fig. 5b;
and Supplementary Fig. S4b for Pearson’s correlation analysis).
23GFPþ HE from the E10.5 AGMþVU also expressed Runx1
and its downstream targets, albeit in fewer cells. Interestingly,
Table 2 | Number of single PAS/AGMþVU cells used in Fluidigm qRT–PCR analysis.
Cell Type E8.5 E9.5 E10.5 E11.5 Total
23GFP EC 39 105 104 37 285
23GFPþ HE 38 97 101 32 268
CD41þ HPC NA 99 113 ND 212
CD45þ HPC NA NA 38 ND 38
AGM, aorta-gonad-mesonephros; EC, endothelial cells, GFP, green ﬂuorescent protein; HE, haemogenic endothelium; HPC, haematopoietic progenitor cells; NA, not applicable (no or very few cells
present at that time point); ND, not done; PAS, para-aortic splanchnopleura; sp, somite pair; VU, vitelline and umbilical.
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Runx1 levels in HE peaked between E9.5 and E10.5 and decreased
rapidly thereafter (Fig. 5b,c). As Runx1 is a critical regulator
of the hematopoietic programme, this suggests that the initiation
of the haematopoietic commitment process in HE, that is, the
speciﬁcation of the hematopoietic fate, occurs in a short burst.
Never did we see any gene expression proﬁle indicative of
coordinated unfolding of the haematopoietic programme in
23GFP cells, in line with their lack of haemogenic potential. In
contrast, approximately half of the E9.5 CD41þ HPCs co-
expressed Runx1, Sfpi1 and/or Gﬁ1 (but not yet Myb), indicative
of a rapid transition of newly speciﬁed HE cells into the CD41þ
pool, also seen from the overlap between these two cell types in
PCA (Fig. 5a). The rapid changes in gene expression seen upon
the induction of Runx1 in HE are consistent with the model
where Runx1 orchestrates the assembly of a haematopoiesis-
speciﬁc pattern of transcription factor binding49. Once the cells
expressed CD41, they expressed higher levels of Runx1 and its
direct targets, upregulated Myb39, Gﬁ1b50 and Itgb3 (CD61
(ref. 43)), and further downregulated Kdr, reﬂecting progressive
locking in of the haematopoietic programme and development
into fully determined CD45þ HPCs (E9.5 and E10.5, Fig. 5b–d
and Supplementary Fig. S4b).
Discussion
Here, we show that a transgenic GFP reporter expressed under
the spatiotemporal control of the Runx1 þ 23 hematopoietic
enhancer allows for the positive isolation of all haemogenic cells,
from mesoderm as well as the major embryonic arteries of the
mouse conceptus. We have used this model to begin to
understand the molecular and temporal regulation of EHT at
the clonal level. To our knowledge, our study is the ﬁrst clonal
functional and molecular analysis of embryonic HE undergoing
EHT. Combined high-throughput single cell functional and
transcriptional analysis allowed us to reveal that EHT is
accompanied by an early loss of endothelial potential along with
a gradual unfolding of the haematopoietic programme, as
opposed to a segregation of haematopoietic and endothelial
programmes in a single cell. Our data show that the process of
commitment to the haematopoietic lineage, consisting sequen-
tially of speciﬁcation and determination of the hematopoietic
programme, is ﬁrst initiated at E9.5 in CD41 23GFPþ HE,
when these cells are still part of the endothelial wall. This
observation places the CD41 23GFPþ HE upstream of recently
identiﬁed CD41lo pre-HSCs51,52, and it will be of interest to assess
the lineal relationship between the two. In conclusion, our results
re-write the concept of haematopoietic speciﬁcation during EHT
and have important implications for the design of future
experiments aimed at obtaining a mechanistic understanding of
EHT, directing the search for key haematopoietic inducing signals
and critical molecular pathways to earlier developmental time
points than previously anticipated. This in turn impacts on the
future generation of deﬁnitive haematopoietic stem and
progenitor cells from embryonic stem/induced pluripotent cells
or via direct reprogramming.
Methods
Timed matings and embryo collection. For timed pregnancies, (CBAC57BL/
6)/F1 females (6–26 weeks old) were mated overnight with 23GFP transgenic males
(6–52 week old, maintained on a mixed (CBAC57BL/6) background. Embryos
were collected in phosphate-buffered saline (PBS; Gibco, Invitrogen) supplemented
with 10% fetal calf serum (FCS; batch tested and obtained from either Biosera or
PAA Laboratories), 50Uml 1 penicillin, and 50 mgml 1 streptomycin (Cambrex
Corporation). E8.5 to E10.5 embryos were staged by counting somite pairs. 23GFP
transgenic embryos were identiﬁed by ﬂuorescence illumination (X-Cite 120;
Improvision) on a Leica MZFLIII microscope. Mice were housed with free access to
food and water. All procedures were in compliance with United Kingdom Home
Ofﬁce regulations and approved by the Ethical Review Committee of the Clinical
School and the Home Ofﬁce.
Dissections and generation of cell suspensions. E8.5 concepti and later stage
yolk sac, PAS/AGM, VU vessels and were dissected in PBS supplemented with 10%
FCS (batch tested and obtained from either Biosera or PAA Laboratories),
50Uml 1 penicillin, and 50 mgml 1 streptomycin (Cambrex Corporation) using
watch makers forceps and 25G needles. Concepti were dissected without the
ectoplacental cone, and in part of the experiments without the head and heart
region. Tissues were pooled and incubated for 20min at 37 C in PBS supple-
mented with 10% FCS, 50Uml 1 penicillin, 50mgml 1 streptomycin and 0.12%
(w/v) of collagenase (Type I, Sigma), and dissociated by pipetting. Suspensions
were washed, and viable cells were counted on the basis of trypan blue (Sigma-
Aldrich) exclusion using a Neubauer haemocytometer.
Flow cytometry and cell sorting. Embryonic cells were isolated by ﬂow cytometry
using a 100 mm nozzle at 30 p.s.i. and o1,500 events per second (MoFlow; Beck-
man Coulter). For single-cell qRT–PCR, cells were sorted directly using FACSAria
III with an 85mm nozzle (Becton Dickinson). Analysis was performed on CyAn
ADP (Beckman Coulter). Antibody staining was carried out on ice and in the dark
for 15min in PBS supplemented with 10% FCS (batch tested and obtained from
either Biosera or PAA Laboratories) and 50Uml 1 penicillin, and 50mgml 1
streptomycin (Cambrex Corporation). Cells were collected into FCS-coated tubes
and recounted prior to plating where possible. Antibodies and conjugates
(Supplementary Table S1) were titrated to determine their optimal concentration of
use. Gates were deﬁned using unstained, single stained and ﬂuorescence minus
onestained cells. Dead cells were excluded based on Hoechst 33258 (Invitrogen)
uptake. Data were acquired and analysed using Summit (BC) or FACS Diva (BD)
software.
Fluorescent microscopy. Embryos were ﬁxed in 4% paraformaldehyde (Electron
Microscopy Sciences) for 1–2 h at 4 C, washed in PBS, and soaked in 15% (w/v)
sucrose for 2–4 h at 4 C. Samples were snap-frozen in Tissue-Tek OCT compound
(Sakura, Siemens Medical Solutions Diagnostics) and sectioned at 10 mm on a Leica
CM3050s cryostat, collected onto Superfrost plus glass slides (VWR) and after air
drying, washed in PBS. For VE-Cadh or CD41 staining, sections were block per-
meated with 10% FCS in 0.05% Tween/PBS for 30min at RT, incubated with
puriﬁed rat anti-mouse VE-Cadh or CD41 antibody (Supplementary Table S1) in
0.05% Tween PBS for 1 h at room temperature (RT), followed by 2 h incubation at
RT with goat anti-rat AlexaFluor555 antibody (10 mgml 1; Invitrogen) in 2%
normal mouse serum and 0.05% Tween/PBS. For Runx1 Ab staining, sections were
permeated with 1% Triton X-100/PBS for 10min at RT, blocked with 10% FCS/
PBS for 30min at RT, incubated with polyclonal rabbit anti-mouse Runx1 antibody
(kind gift of the Jessel lab) in 10% FCS/PBS overnight at 4 C and stained for 2 h at
RT with goat anti-rabbit AlexaFluor555 antibody (10mgml 1; Invitrogen) in 2%
normal mouse serum and PBS. Slides were stained with TO-PRO-3 iodide (0.2 mM
ﬁnal concentration; Invitrogen) in PBS for 20min, washed in PBS and coverslipped
with Vectashield mounting medium containing 40 ,6-diamidino-2-phenylindole
(DAPI, Vector Laboratories). Sections were analysed and photographed with an
Olympus BX51 camera (Olympus), Radiance 2000 Confocal Scanning System
(Bio-Rad), and Laser Sharp 2000 software (Zeiss). Images were processed using
Confocal Assistant 3.0 (CAS) and Adobe Photoshop (Adobe systems, Europe).
Haematopoietic progenitor assay. Colony-forming unit-culture (CFU-C) assays
were performed using Methocult M3434 (Stem Cell Technologies). Cells were
plated in duplicate in 35mm culture dishes according to manufacturer’s instruc-
tions. Cultures were grown at 37 C with 5% CO2 with colonies scored after 7 days.
OP9 maintenance. OP9 cells (kindly provided by M. Yoder, Indianapolis) were
maintained in aMEM (Gibco) with 20% deﬁned FCS (Hyclone) and 0.22% sodium
bicarbonate (Gibco) at 37 C, 5% CO2. Cells were passaged every 3 days using
0.05% Trypsin/EDTA (Gibco) at 37 C for 6min. For co-culture experiments, cells
were resuspended in aMEM with 10% FCS and 1 10 4 M 2-mercaptoethanol
and plated at 23 103 cells per cm2 24 h before the experiment.
OP9 cocultures. For single cell and limiting dilution cocultures, cells were directly
sorted onto conﬂuent OP9 stroma; for all other cocultures, cells were sorted and
recounted prior to plating. Cocultures of OP9 with E7.5 cells were supplemented
with 100 ngml 1 SCF and grown for 5–7 days. For E8.5 to E10.5 haemogenic and
single-cell assays, cultures were supplemented with 10 ngml 1 IL7, 10 ngml 1
SCF and 10 ngml 1 Flt-3-ligand, and incubated for 8–10 days at 37 C, 5% CO2.
The haematopoietic nature of the cells generated in the OP9 cocultures was
assessed by microscopy, ﬂow cytometry and/or May-Gru¨nwald Giemsa staining of
cytospins. For endothelial assays, cells were cultured with 50 ngml 1 recombinant
murine vascular endothelial growth factor for 4 days at 37 C 5% CO2. All cyto-
kines were purchased from Peprotech (Supplementary Table S2). To visualize
endothelial cell growth, cultures were stained with rat anti-mouse CD31
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(MEC13.3) followed by alkaline phosphatase-conjugated goat anti-rat and detected
by Vectablue AP Substrate Kit III (Vector). Images were collected on an Olympus
1 51 microscope equipped with a Jenoptik ProgRes C14 camera, and processed
using Adobe Photoshop.
Microﬂuidic Quantitative RT–PCR. Multiplex qRT–PCR was performed using the
Fluidigm (Biomark) platform. TaqMan assays (Applied Biosystems; Supplementary
Table S3) were pooled to a ﬁnal concentration of 0.2 . Cells were harvested
directly into 10ml RT-PreAmp Master Mix (consisting of 5 ml CellsDirect 2
Reaction Mix (Invitrogen), 2.5 ml 0.2 assay mix, 1.2 ml RT/Taq enzyme (Cells-
Direct qRT–PCR kit, Invitrogen), 1.2 ml TE buffer (Invitrogen) and 0.1 ml
SUPERase-In (Ambion)). Collected samples were immediately vortexed and spun
to aid cell lysis. Reverse transcription was performed at 50 C for 15min and
inactivated at 95 C for 5min. In the same tube, cDNA was ampliﬁed by 22 cycles
at 95 C for 15 s followed by 60 C for 4min. The pre-ampliﬁed mix was imme-
diately frozen at  20 C until further analysis. Samples were diluted ﬁvefold and
analysed on 48.48 Dynamic Arrays according to manufacturers’ instructions, using
the following PCR conditions: 95 C for 10min, followed by 40 cycles of 95 C for
15 s and 60 C for 1min (Fluidigm, BioMark). Ampliﬁcation curves were quality
ﬁltered using a thresholdo0.65, and Ct thresholds were set for each assay with the
same thresholds used across all experiments. Ct values were calculated by BioMark
Real-time PCR Analysis software (Fluidigm). Data were exported to Excel as.csv
ﬁles for subsequent analysis.
Microﬂuidic quantitative RT–PCR analysis. For population level analysis, two
independent sorting experiments were performed each with 2–3 biological repli-
cates of 25 cells. Data were analysed by the DCt method53, normalized to Hprt1 and
BAct. For single-cell analysis, 20 haematopoietic and endothelial-afﬁliated genes
and four housekeeping assays were analysed in duplicate with positive (20 cell) and
negative (0 cell) controls analysed on each 48.48 array. Duplicate readings were
averaged, and the data were ﬁltered according to no template control reactions,
(0 cell), and excluding Ct427. Genes that were not expressed were set to a Ct of 27.
All Ct values were subtracted from the no template background of 27. Samples were
included for downstream analysis based on the expression of Atp5a1 and Ubc with
DCt values calculated using the mean Ct value of Atp5a1 and Ubc for each cell.
Cdh5 and Cbfb assays were not used for single-cell analysis based on poor
ampliﬁcation curves. Hierarchical clustering, Pearson’s correlation and principal
component analyses were performed in R (http://www.r-project.org) and did not
include housekeeping genes.
Microarray analysis. Whole-genome expression analysis was performed using
total RNA extracted using Trizol according to manufacturers’ instructions (Invi-
trogen) and puriﬁed using RNeasy Micro kit (Qiagen). With the same total amount
of input RNA, triplicate samples were ampliﬁed with a WT-Ovation Pico RNA
Ampliﬁcation System followed by WT-Ovation cDNA Biotin Module V2 for
cDNA labelling (NuGEN) and fragmentation, and were ﬁnally hybridized to
Affymetrix Mouse Genome 430 2.0 arrays by standard protocols (Affymetrix) at
the Stanford Protein and Nucleic Acid facility. The CEL ﬁles were normalized using
RMA in the affy package54 and a threshold of log expression value of 5 in at least
one sample was used for selecting informative probes. Signiﬁcantly differentially
expressed genes were selected using the LIMMA55 package with41.0 absolute log
fold change and adjusted (Benjamini Hockberg) Po0.05 for comparisons of HE
versus E and HPC versus non-HPC samples. The union of these was then used to
select probes for the heatmap generated by the gplots library (http://www.CRAN.R-
project.org/package=gplots). Gene ontology enrichment analysis and annotation of
the probe sets was done using Metacore (http://www.thomsonreuters.com/
metacore/), which uses the Multicore variation of the Fisher’s exact test and adjusts
for multiple sample testing using FDR.
Statistics. Results, unless otherwise indicated, are expressed as mean±s.d.
Two-tailed Student’s t-test was used to determine the level of signiﬁcance with
Po0.05 considered statistically signiﬁcant and indicated by an asterisk.
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